From: A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial
Percentage point reduction
Natural log of reduction
SD estimate
Total sample size
Allowing for 10% attrition
11
−0.117
0.34
366
407
14
−0.150
216
240
0.4
492
547
300
333